Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.

Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.

Item
http://www.wikidata.org/entity/Q34093209
High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.Identification of Protein-Excipient Interaction Hotspots Using Computational Approaches.Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools.Liquid formulations for long-term storage of monoclonal IgGs.Cell culture media impact on drug product solution stability.Characterizing monoclonal antibody formulations in arginine glutamate solutions using (1)H NMR spectroscopy.Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.Liquid formulations for stabilizing IgMs during physical stress and long-term storage.Stabilization studies on bacterially produced human paraoxonase 1 for improving its shelf life.
P2860

Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.

Item
http://www.wikidata.org/entity/Q34093209
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Formulation design and high-th ...... monoclonal antibody solutions.
@ast
Formulation design and high-th ...... monoclonal antibody solutions.
@en
Formulation design and high-th ...... monoclonal antibody solutions.
@nl
type
label
Formulation design and high-th ...... monoclonal antibody solutions.
@ast
Formulation design and high-th ...... monoclonal antibody solutions.
@en
Formulation design and high-th ...... monoclonal antibody solutions.
@nl
prefLabel
Formulation design and high-th ...... monoclonal antibody solutions.
@ast
Formulation design and high-th ...... monoclonal antibody solutions.
@en
Formulation design and high-th ...... monoclonal antibody solutions.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Formulation design and high-th ...... monoclonal antibody solutions.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921